Scaffold Redesign
Scaffold Redesign is a methodological contribution in medicinal chemistry that involves the systematic modification of a molecular scaffold to generate novel chemotypes while retaining desired biological activity, distinguishing it from other scaffold hopping approaches by prioritizing structural innovation and patentability.
109
Publications
3.6K
Citations
802
Authors
218
Institutions
Publications per year
2017–2026
35
Parents
109
Andreas Gollner, Dorothea Rudolph, Heribert Arnhof et al. · Journal of Medicinal Chemistry · 2016 · 121 citations
Ignacio Colomer, Christopher J. Empson, Philip G. E. Craven et al. · Chemical Communications · 2016 · 88 citations · Full text
1–5 of 109
802
3
h-index
3
h-index
3
h-index
2
h-index
2
h-index
1–5 of 802
218

Chinese Academy of Sciences
Beijing, China
6 h-index
34 publications
714 citations
University of Cambridge
Cambridge, United Kingdom
4 h-index
16 publications
1.1K citations

Centre National de la Recherche Scientifique
Paris, France
4 h-index
10 publications
239 citations

University of Leeds
Leeds, United Kingdom
4 h-index
20 publications
1K citations
University of Chinese Academy of Sciences
Beijing, China
3 h-index
9 publications
131 citations
University of Bonn
Bonn, Germany
3 h-index
7 publications
165 citations
University of Sussex
Brighton, United Kingdom
3 h-index
8 publications
250 citations

Al-Azhar University
Cairo, Egypt
2 h-index
2 publications
96 citations
1–8 of 218
11 publications · 259 citations
11
h-index
11 publications · 198 citations
11
h-index
11 publications · 276 citations
10
h-index
7 publications · 545 citations
7
h-index
6 publications · 465 citations
6
h-index
1–5